Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

D

DYN

Dyne Therapeutics Inc

26.07

Aug 05 • 7:15 AM ET +0.10 (0.37%)

Healthcare Biotechnology USA Mid NASD

Peers: ALMS ERAS TNGX APGE KRYS KYMR NUVL BMRN INCY RYTM

| Held by: XBI VTI IWM VXF VB IBB IWN VBR SCHA VTWO

Scroll to Statements

Index	RUT
Market Cap	4.87B
Enterprise Value	4.20B
Income	-519.41M
Sales	0.00M
Book/sh	4.24
Cash/sh	4.81
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	258
IPO	Sep 17, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	6.15
P/C	5.42
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.02
Current Ratio	12.02
Debt/Eq	0.33
LT Debt/Eq	0.30
Option/Short	Yes / Yes

EPS (ttm)	-3.33
EPS next Y	-3.26
EPS next Q	-0.86
EPS this Y	0.41%
EPS next Y	5.58%
EPS next 5Y	10.50%
EPS past 3/5Y	-2.41% 3.39%
Sales past 3/5Y	- -
EPS Y/Y TTM	13.71%
Sales Y/Y TTM	-
EPS Q/Q	-10.86%
Sales Q/Q	-
Earnings	Jul 29 AMC
EPS/Sales Surpr.	-44.23% -

Insider Own	18.43%
Insider Trans	-12.65%
Inst Own	83.37%
Inst Trans	3.65%
ROA	-60.29%
ROE	-81.57%
ROIC	-56.70%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.57%
SMA50	20.80%
SMA200	35.39%
Trades

Shs Outstand	165.67M
Shs Float	152.33M
Short Float	14.11%
Short Ratio	10.07
Short Interest	21.49M
52W High	26.26 -0.74%
52W Low	9.89 163.56%
Volatility	5.65% 6.16%
ATR (14)	1.30
RSI (14)	65.86
Beta	1.08
Rel Volume	0.01
Avg Volume	2.13M
Volume	1,122

Perf Week	3.85%
Perf Month	9.38%
Perf Quarter	49.21%
Perf Half Y	37.48%
Perf YTD	33.26%
Perf Year	148.96%
Perf 3Y	125.68%
Perf 5Y	38.06%
Perf 10Y	-
Recom	1.18
Target Price	39.40
Prev Close	25.97
Price	26.07
Change	0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)